Relmada Therapeutics, Inc. (RLMD)

Unlocking innovative treatments for the improvement of human health

News

View all news

News - May 12, 2025

Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

News - May 8, 2025

Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

News - Apr 28, 2025

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

Events

View all events

Event - May 23, 2025 9:30 AM EDT

2025 Annual Meeting of Stockholders

Read more

Event - May 12, 2025 4:30 PM EDT

Q1 2025 Financial Results Conference Call

Read more

Event - Apr 28, 2025 4:30 PM EDT

Virtual KOL Event

Read more